Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 16.85
-0.15 (-0.88%)
At close: Jul 31, 2026
Xlife Sciences AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 96 | 142 | 146 | 279 | 157 | - | |
Market Cap Growth | -28.49% | -2.32% | -47.72% | 77.76% | - | - |
Enterprise Value | 241 | 290 | 295 | 434 | 321 | - |
Last Close Price | 16.85 | 24.70 | 25.40 | 49.90 | 29.70 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 4.26 | 18.75 | 10.97 | - |
PS Ratio | 349.00 | 517.45 | 174.69 | 282.22 | 152.66 | - |
PB Ratio | 0.26 | 0.38 | 0.37 | 0.76 | 0.47 | - |
P/TBV Ratio | 2.93 | 4.34 | 4.04 | - | - | - |
P/FCF Ratio | - | - | - | 1766.87 | - | - |
P/OCF Ratio | - | - | - | 1623.87 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | 1053.24 | 353.76 | 439.10 | 311.96 | - |
EV/FCF Ratio | - | - | - | 2749.02 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.16 | 0.16 | 0.15 | 0.16 | 0.18 | 0.20 |
Debt / FCF Ratio | - | - | - | 359.14 | - | - |
Net Debt / Equity Ratio | 0.16 | 0.16 | 0.15 | 0.16 | 0.18 | 0.19 |
Net Debt / EBITDA Ratio | -18.01 | -18.01 | -17.46 | -12.88 | -11.92 | -11.83 |
Net Debt / FCF Ratio | -46.68 | -46.68 | -136.58 | 357.75 | -13.07 | -13.73 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover | 7.13 | 7.13 | - | - | - | - |
Quick Ratio | 0.10 | 0.10 | 1.53 | 3.11 | 0.61 | 1.05 |
Current Ratio | 0.10 | 0.10 | 1.54 | 3.11 | 0.65 | 1.06 |
Return on Equity (ROE) | -7.05% | -7.05% | 7.54% | 2.64% | 2.67% | 23.71% |
Return on Assets (ROA) | -3.73% | -3.73% | -2.30% | -2.53% | -2.70% | -0.98% |
Return on Invested Capital (ROIC) | -7.31% | -7.11% | -4.41% | -4.96% | -5.39% | -1.87% |
Return on Capital Employed (ROCE) | -6.30% | -6.30% | -3.60% | -4.00% | -4.30% | -1.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -22.43% | -15.13% | 23.50% | 5.33% | 9.12% | - |
FCF Yield | -1.33% | -0.90% | -0.30% | 0.06% | -2.95% | - |
Buyback Yield / Dilution | 21.85% | 21.85% | -1.34% | 0.17% | -17.26% | -4.77% |